Japanese Medical Equipment Stock News

Why Money Forward’s Updated FY2026 Guidance Matters for Investors Money Forward (TSE:3994) updated its fiscal 2026 guidance, projecting net sales between ¥60,500 million and ¥62,300 million, with outcomes ranging from a ¥500 million operating loss to a ¥1,500 million operating profit. The company now forecasts a loss attributable to owners of parent between ¥3,200 million and ¥700 million, citing strong Fintech performance in its Business segment and expected net sales from operational...

The market seemed underwhelmed by last week's earnings announcement from Bewith, Inc. ( TSE:9216 ) despite the healthy...

Eisai and Biogen recently reported real-world data from the three-year LEADER study showing that nearly 83% of early Alzheimer’s patients on Leqembi remained stable or improved over about 17 months, and secured U.S. FDA approval for once-weekly subcutaneous Leqembi Iqlik as an at-home initiation option. These updates suggest that Leqembi’s convenience, persistence on therapy and consistency across diverse patient groups could be increasingly important drivers of its clinical and commercial...

SMS stock: recent performance and business context SMS (TSE:2175) has drawn attention after a strong run recently, with the stock up about 20% over the past month and roughly 37% in the past 3 months, prompting fresh interest in its underlying business. The company focuses on information infrastructure for Japan’s aging society, with revenue of ¥64,735 and a reported loss of ¥14,317. This means investors are weighing solid annual revenue growth against ongoing profitability challenges. See...

Ichigo Q1 2027 earnings call as a fresh catalyst Ichigo (TSE:2337) recently released its Q1 2027 pre recorded earnings call on July 15, 2026, giving investors fresh information on its real estate, hotel, and clean energy businesses in Japan. See our latest analysis for Ichigo. Ichigo's Q1 2027 earnings update comes after a mixed share price pattern, with the stock up 4.11% over the last day but down 15.98% over 90 days. Meanwhile, 1 year and 3 year total shareholder returns of 17.47% and...

Why the FDA sNDA for cefiderocol matters for Shionogi stock The FDA sNDA acceptance for Shionogi (TSE:4507) antibiotic cefiderocol in pediatric hospital and urinary infections highlights a fresh regulatory milestone that could influence how investors think about the company s long term revenue mix. See our latest analysis for Shionogi. Investors have seen Shionogi s share price gain 3.45% over the past month, even after a roughly 10.49% decline over 90 days. At the same time, the 1 year total...

In July 2026, Yamato Holdings Co., Ltd. established a "Corporate Value Enhancement Committee," a six-member advisory body under the Board composed mainly of outside directors and chaired by President Toshiyuki Sakurai to focus on maximizing corporate value. This new committee, sitting alongside Yamato’s existing nomination, compensation, compliance, and risk bodies, signals a reinforced governance framework centered on independent oversight of long-term value creation. We will now explore...

MediPal Holdings (TSE:7459) has updated investors with higher full year dividend guidance and revised earnings expectations after completing its tender offer for PALTAC Corporation, which shifts more of PALTAC's profit fully onto its books. See our latest analysis for MediPal Holdings. Recent moves suggest growing interest in MediPal Holdings, with a 1 month share price return of 9.92% and a 1 year total shareholder return of 19.90%. This points to building momentum around the revised...

Tsuruha Holdings Inc. previously reported first-quarter 2026 results, with sales rising to ¥636,886 million from ¥272,530 million and net income increasing to ¥13,477 million from ¥11,112 million a year earlier. Despite higher sales and net income, basic earnings per share from continuing operations fell to ¥29.75 from ¥45.66, hinting at changes in share count or profit mix that matter for investors. Next, we examine how this mix of rapid sales expansion and lower earnings per share shapes...

Europe’s record heat is turning air conditioning from a luxury into critical infrastructure, and that shift is starting to influence where capital flows. As governments debate funding for cooling in hospitals and schools and push for greener, more efficient systems, some stocks exposed to this climate adaptation story could see fresh attention while others may face tougher questions. This article explores how the news-driven theme around European air conditioning expansion connects to three...

Daiwa Office Investment (TSE:8976) has reported FY 2026 results with second half revenue of ¥16.5 billion and basic EPS of ¥8,468.62, supported by trailing twelve month revenue of ¥32.6 billion and EPS of ¥16,463.91 that sit above the prior year period. The company has seen revenue move from ¥15.2 billion in the second half of FY 2025 to ¥16.1 billion in the first half of FY 2026 and then to ¥16.5 billion in the latest half, while EPS rose from ¥7,347.71 to ¥7,995.98 and then ¥8,468.62 over...

SOSiLA Logistics REIT (TSE:2979) has reported solid top line figures for FY 2026, with second half revenue at ¥4,280 million and basic EPS of ¥2,380.76, set against trailing twelve month revenue of ¥9,064.32 million and EPS of ¥5,126.75. The trust recorded revenue of ¥4,326 million and EPS of ¥2,452.23 in the first half of FY 2025, rising to revenue of ¥4,784.32 million and EPS of ¥2,745.99 in the first half of FY 2026. These figures provide investors with a clearer picture of how the latest...

Alinco (TSE:5933) opened its new fiscal year with Q1 2027 revenue of ¥16.4 billion and basic EPS of ¥23.56, framing the latest set of numbers that investors are weighing against the current share price of ¥1,061. The company has seen quarterly revenue move from ¥15.4 billion and EPS of ¥20.07 in Q1 2026 to ¥16.4 billion and EPS of ¥23.56 in Q1 2027, while trailing twelve month EPS sits at ¥91.36. This presents a picture of modest earnings growth alongside relatively thin but edging-up profit...

Shareholders will be ecstatic, with their stake up 35% over the past week following Saizeriya Co.,Ltd. 's ( TSE:7581...

As Asian markets navigate through a period of volatility, driven by shifts in technology stocks and geopolitical tensions, investors are keenly observing the performance of small-cap indices like the S&P 600. With inflation easing and rate hike expectations diminishing, there is an opportunity for discerning investors to explore potential hidden gems that may offer resilience and growth amid these dynamic conditions.

Izumi Q1 earnings put recent performance in focus Izumi (TSE:8273) has drawn investor attention after reporting first quarter results to May 31, 2026, with sales of ¥125,235 million and net income of ¥4,528 million, both higher than a year earlier. See our latest analysis for Izumi. Izumi's share price has risen around 6% over the past month, while the 1 year total shareholder return is close to flat and the 3 and 5 year total shareholder returns remain mildly negative, suggesting only modest...

Eisai (TSE:4523) is back in focus after fresh Alzheimer’s data and a new at-home dosing option for Leqembi. These developments together reshape how investors might think about the company’s neurology franchise. See our latest analysis for Eisai. Eisai’s latest Alzheimer’s updates arrive alongside a 12.12% 1 month share price return, though the share price is still down 7.04% year to date, while the 1 year total shareholder return of 16.39% contrasts with weaker 3 and 5 year total shareholder...

The International Atomic Energy Agency has again verified that ALPS treated water discharged from Fukushima by Tokyo Electric Power Company Holdings (TSE:9501) complies with Japan’s tritium limits and international safety standards, keeping regulatory scrutiny firmly in focus. See our latest analysis for Tokyo Electric Power Company Holdings. While the latest IAEA confirmation reinforces confidence around Fukushima water management, Tokyo Electric Power Company Holdings’ share price tells a...

Dentsu Group has appointed Ajay Gupte as chief operating officer for South Asia, working alongside CEO Harsha Razdan to drive transformation, efficiency and a more agile, collaborative network across the region. By bringing in a leader with deep experience in media, digital transformation and large-scale business change, Dentsu is explicitly tying its South Asia operational overhaul to its broader Business to Business to Society model and client-centric growth ambitions. We’ll now examine...

COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026. At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...

SHIFT (TSE:3697) drew fresh attention after revising full year guidance, raising net sales expectations while cutting profit forecasts due to higher non operating expenses, and introducing a dividend outlook where none had been planned. See our latest analysis for SHIFT. The revised guidance and dividend move come after a sharp 1 day share price return of 9.36% and a 1 month share price return of 15.22%. However, the year to date share price return of SHIFT is still down 22.21%, and the 1...

In July 2026, The Monogatari Corporation reported past sales results for June, the fourth quarter, and the full year ended June 2026, showing slightly slower monthly and quarterly growth versus the prior year but a marginal uptick in full-year sales growth. This mix of short-term deceleration and steady full-year expansion gives investors a more nuanced view of how Monogatari’s restaurant network is evolving across different time horizons. Next, we will examine how this pattern of softer...

Tokyo Steel Manufacturing (TSE:5423) opened Q1 2027 with revenue of ¥72,927 million and basic EPS of ¥18.40, setting the tone for a period where trailing figures and recent quarters tell a mixed story on profitability. Over the last five reported quarters, revenue has moved between ¥60,032 million and ¥73,862 million while basic EPS has ranged from ¥8.19 to ¥47.11, giving investors a clear view of how earnings have tracked against a relatively tight revenue band. With trailing margins thinner...

As you might know, TKP Corporation ( TSE:3479 ) recently reported its quarterly numbers. It was a mildly positive...